Profile data is unavailable for this security.
About the company
JIANMIN PHARMACEUTICAL GROUP CO., LTD., formerly Wuhan Jianmin Pharmaceutical Groups Co. Ltd, is a China-based company, principally engaged in the research and development, manufacture, wholesale and retailing of pharmaceuticals. The Company operates its businesses through two segments, including Pharmaceutical Industry and Pharmaceutical Business. The Pharmaceutical Industry segment is engaged in the research and development and manufacture of pharmaceuticals. Its products are mainly applied in children, women and the elderly, among others. The Pharmaceutical Business segment is engaged in the wholesale and retailing of pharmaceuticals. Its products include traditional Chinese medicine, Western medicine, health products, medical equipment and chemical agents. It distributes its products mainly in domestic market.
- Revenue in CNY (TTM)4.17bn
- Net income in CNY521.42m
- Incorporated1993
- Employees2.50k
- LocationJianmin Pharmaceutical Group Co LtdNo.484 Yingwu Avenue, Hanyang DistrictWUHAN 430052ChinaCHN
- Phone+86 2 784523350
- Fax+86 2 784523350
- Websitehttp://www.whjm.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Guangxi Wuzhou Zhongheng Group Co Ltd | 3.23bn | 156.14m | 7.63bn | 2.89k | 48.00 | 1.14 | -- | 2.36 | 0.0454 | 0.0454 | 0.9413 | 1.91 | 0.2766 | 1.96 | 3.41 | 1,120,149.00 | 0.9542 | 2.26 | 1.51 | 3.38 | 53.66 | 72.05 | 3.45 | 7.27 | 2.38 | -- | 0.1795 | 45.67 | 14.10 | -1.26 | 6.69 | -32.76 | -4.56 | -30.12 |
| Shenzhen Chipscreen Biosciences Co Ltd | 547.79m | 103.01m | 7.70bn | 1.06k | 73.24 | 4.55 | -- | 14.06 | 0.2578 | 0.2578 | 1.33 | 4.15 | 0.1761 | 1.66 | 3.97 | 518,248.70 | 2.14 | 1.32 | 2.61 | 1.54 | 86.99 | 93.29 | 12.17 | 6.97 | 2.99 | -- | 0.4037 | 0.00 | -1.18 | 28.81 | 408.09 | 23.31 | 10.23 | -- |
| Vcanbio Cell & Gene Engineering Corp Ltd | 1.61bn | 109.23m | 7.78bn | 2.21k | 68.97 | 2.04 | -- | 4.83 | 0.2334 | 0.2334 | 3.44 | 7.88 | 0.3034 | 2.01 | 2.86 | 728,818.10 | 1.97 | 1.13 | 2.79 | 1.61 | 67.97 | 67.76 | 6.51 | 3.84 | 1.52 | 6.93 | 0.0284 | 0.00 | 2.24 | 3.78 | -5.78 | 12.43 | -7.11 | -- |
| China Animal Husbandry Industry Co., Ltd | 5.47bn | 339.08m | 7.96bn | 4.33k | 22.65 | 1.37 | -- | 1.46 | 0.3321 | 0.3321 | 5.36 | 5.48 | 0.6331 | 4.13 | 4.89 | 1,264,384.00 | 3.33 | 6.23 | 4.71 | 9.01 | 18.95 | 24.29 | 5.26 | 8.69 | 1.86 | -- | 0.2017 | 31.20 | -8.24 | 4.04 | -26.73 | -0.6127 | 24.20 | -3.77 |
| Jianmin Pharmaceutical Group Co Ltd | 4.17bn | 521.42m | 8.06bn | 2.50k | 14.86 | 3.30 | -- | 1.93 | 3.41 | 3.41 | 27.26 | 15.35 | 1.04 | 5.81 | 4.34 | 1,669,960.00 | 13.09 | 10.87 | 23.66 | 19.11 | 43.70 | 43.04 | 12.56 | 9.32 | 1.26 | -- | 0.1891 | 37.15 | 15.72 | 14.28 | 27.78 | 45.05 | 8.77 | 43.10 |
| Youcare Pharmaceutical Group Co Ltd | 4.04bn | 168.83m | 8.33bn | 3.18k | 49.24 | 2.28 | -- | 2.06 | 0.3757 | 0.3757 | 8.97 | 8.13 | 0.6518 | 2.07 | 4.09 | 1,269,471.00 | 2.76 | 7.11 | 4.15 | 11.65 | 59.54 | 64.14 | 4.24 | 8.07 | 1.42 | -- | 0.2079 | 60.95 | -7.61 | 1.05 | -44.84 | -7.16 | 23.40 | -- |
| Jinyu Bio-Technology Co Ltd | 1.58bn | 282.51m | 8.34bn | 1.65k | 27.90 | 1.43 | -- | 5.27 | 0.2588 | 0.2588 | 1.44 | 5.05 | 0.2365 | 2.06 | 1.98 | 956,543.20 | 4.09 | 4.82 | 4.79 | 5.68 | 57.97 | 58.78 | 17.28 | 19.91 | 3.33 | -- | 0.0043 | 36.41 | 4.55 | -3.37 | 34.63 | -17.77 | -12.92 | -25.56 |
| Nanjing Vazyme Biotech Co Ltd | 1.29bn | -15.12m | 8.34bn | 2.70k | -- | 2.07 | -- | 6.49 | -0.0368 | -0.0368 | 3.27 | 10.07 | 0.2191 | 0.9761 | 2.85 | 476,061.10 | -0.286 | 13.16 | -0.3724 | 15.92 | 71.31 | 70.50 | -1.31 | 23.92 | 2.97 | -- | 0.2154 | 32.20 | -63.97 | 49.74 | -111.94 | -- | 48.61 | -- |
Data as of Jun 28 2024. Currency figures normalised to Jianmin Pharmaceutical Group Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
23.11%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| E Fund Management Co., Ltd.as of 31 Dec 2023 | 11.63m | 7.63% |
| ICBC Credit Suisse Asset Management Co., Ltd.as of 31 Dec 2023 | 7.33m | 4.81% |
| GF Fund Management Co., Ltd.as of 31 Dec 2023 | 5.26m | 3.45% |
| Zhong Ou Asset Management Co., Ltdas of 31 Dec 2023 | 2.47m | 1.62% |
| Fullgoal Fund Management Co., Ltd.as of 30 Sep 2023 | 2.39m | 1.57% |
| China Southern Asset Management Co., Ltd.as of 31 Dec 2023 | 1.38m | 0.91% |
| China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 1.36m | 0.89% |
| China Merchants Fund Management Co., Ltd.as of 31 Dec 2023 | 1.25m | 0.82% |
| Great Wall Fund Management Co., Ltd.as of 31 Dec 2023 | 1.13m | 0.74% |
| Galaxy Asset Management Co., Ltd.as of 31 Dec 2023 | 1.01m | 0.67% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
